The FDA announced on Feb. 7, 2023, that Datascope Corp. is recalling Cardiosave Hybrid intra-aortic balloon pumps due to an unexpected shutdown hazard. The agency said the devices may lose communication between components, interrupting therapy and threatening patient stability.
How to tell if you have it
- Brand: Datascope
- Product: Cardiosave Hybrid
- Model Nos.: 0998-00-0800-31, 0998-00-0800-32, 0998-00-0800-33, 0998-00-0800-34, 0998-00-0800-35, 0998-00-0800-45, 0998-00-0800-52, 0998-00-0800-53, 0998-00-0800-55, 0998-00-0800-65, 0998-UC-0800-31*, 0998-UC-0800-33*, 0998-UC-0800-52*, 0998-UC-0800-53*, 0998-00-0800-55*
- Units: 4793 in the US; 4407 outside the US
The hazard
The FDA said an unexpected shutdown of the intra-aortic balloon pump may occur due to loss of communication between the Executive Processor PCBA and the Video Generator PCBA. This interruption to therapy may threaten the hemodynamic stability of the supported patient as the user is left unaware to the status of the Cardiosave IABP.
Context
GovInfoNow's records show Datascope Corp. has 29 other recalls on record since June 17, 2019. Other recent recalls include a Datascope Battery Charging Station recall on Feb. 6, 2026, and a Datascope CS100 IABP software update needed on Jan. 23, 2026. Other recent recalls of similar products include a Fresenius Kabi Ivenix Infusion System Software Recall on May 6, 2026.